SOLID-STATE PROPERTIES AND SOLUBILITY STUDIES OF NOVEL PHARMACEUTICAL COCRYSTAL OF ITRACONAZOLE

Objective: Pharmaceutical cocrystal is a promising method to improve the solubility of active pharmaceutical ingredients (APIs). Itraconazole (ITZ) is a BCS class II antifungal drug with poor aqueous solubility, therefore an attempt was made to improve the solubility of ITZ using cocrystallization technique. In this work, six novel pharmaceutical cocrystals of ITZ with various coformers, including 4-hydroxybenzoic acid (4HBA), trans-cinnamic acid (TCA), suberic acid (SUB), sebacic acid (SBC), 1-hydroxy-2-naphthoic acid (1H2N), and benzamide (BZD) were prepared.Methods: ITZ cocrystals was prepared by solvent evaporation process. The cocrystals produced were characterized using powder x-ray diffraction (PXRD), differential scanning calorimetry (DSC), thermogravimetric analysis (TGA) and fourier transform infrared (FTIR) spectroscopy. Solubility analysis was performed to evaluate the cocrystals.Results: PXRD and DSC analysis revealed that the pattern of all ITZ cocrystals was distinguishable from the individual compounds which indicates the formation of new phase. The solubility of ITZ and its cocrystals from highest to lowest after 24 h in 0.1 N HCl solution (pH 1.2) follows the order ITZ-TCA (1.97-fold), ITZ-SBC (1.09-fold), ITZ, ITZ-1H2N (0.58-fold) and ITZ-4HBA (0.46-fold).Conclusion: This study demonstrates that the selection of coformers has pronounced an impact on the physicochemical properties of ITZ. Based on this study, it can be concluded that cocrystallization offers a valuable way to improve the solubility of ITZ.

• Publication year

  2018

• Venue

  International Journal of Applied Pharmaceutics

• Publication date

  2018-09-08

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.22159/IJAP.2018V10I5.26663
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of Crystal Structure and Polymer Excipients on the Melt Crystallization Kinetics of Itraconazole Polymorphs

  2017cited by this paper
• Interrelation of the dissolution behavior and solid‐state features of acetazolamide cocrystals

  2017cited by this paper
• Physicochemical and mechanical properties of paracetamol cocrystal with 5-nitroisophthalic acid.

  2016cited by this paper
• SIMULTANEOUS COCRYSTALLIZATION AND MICRONIZATION OF PARACETAMOL-DIPICOLINIC ACID COCRYSTAL BY SUPERCRITICAL ANTISOLVENT (SAS)

  2016cited by this paper
• Crystallization of Itraconazole Polymorphs from Melt

  2016cited by this paper
• SOLUBILITY ENHANCEMENT OF KETOCONAZOLE VIA SALT AND COCRYSTAL FORMATION

  2015cited by this paper
• New forms of old drugs: improving without changing

  2015influential reference
• Thermodynamic characteristics of cocrystal formation and melting points for rational design of pharmaceutical two-component systems

  2015influential reference
• Soluble Salts and Cocrystals of Clotrimazole

  2015cited by this paper
• Baicalein-nicotinamide cocrystal with enhanced solubility, dissolution, and oral bioavailability.

  2014cited by this paper
• Kinetic Entrapment of a Hidden Curcumin Cocrystal with Phloroglucinol

  2014influential reference
• Solubility Advantage of Tenoxicam Phenolic Cocrystals Compared to Salts

  2013cited by this paper
• Diversity in Itraconazole Cocrystals with Aliphatic Dicarboxylic Acids of Varying Chain Length

  2013cited by this paper
• Soluble Cocrystals of the Xanthine Oxidase Inhibitor Febuxostat

  2013influential reference
• COCRYSTALIZATION: AN ALTERNATIVE APPROACH FOR SOLID MODIFICATION

  2013cited by this paper
• Pharmaceutical Co-Crystals of Pyrazinecarboxamide (PZA) with Various Carboxylic Acids: Crystallography, Hirshfeld Surfaces, and Dissolution Study

  2013cited by this paper
• Polymorphs, Salts, and Cocrystals: What’s in a Name?

  2012cited by this paper
• Acid–base crystalline complexes and the pKa rule

  2012cited by this paper
• Coformer selection based on degradation pathway of drugs: a case study of adefovir dipivoxil-saccharin and adefovir dipivoxil-nicotinamide cocrystals.

  2012cited by this paper
• Ditosylate Salt of Itraconazole and Dissolution Enhancement Using Cyclodextrins

  2012cited by this paper
• Preparation and Solid-State Characterization of Three Novel Multicomponent Solid Forms of Oxcarbazepine: Improvement in Solubility through Saccharin Cocrystal

  2012cited by this paper
• Crystal design approaches for the synthesis of paracetamol co-crystals

  2012cited by this paper
• Novel furosemide cocrystals and selection of high solubility drug forms.

  2012cited by this paper
• Enhancing the Hygroscopic Stability of S-Oxiracetam via Pharmaceutical Cocrystals

  2012cited by this paper
• Improvement in physicochemical properties of ezetimibe using a crystal engineering technique

  2012cited by this paper
• Physical stability of salts of weak bases in the solid-state.

  2011cited by this paper
• Vibrational Spectroscopic Studies of Cocrystals and Salts. 3. Cocrystal Products Formed by Benzenecarboxylic Acids and Their Sodium Salts

  2010cited by this paper
• The influence of aqueous content in small scale salt screening--improving hit rate for weakly basic, low solubility drugs.

  2010cited by this paper
• Effects of Crystal Form on Solubility and Pharmacokinetics: A Crystal Engineering Case Study of Lamotrigine

  2010cited by this paper
• Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica.

  2008cited by this paper
• Physical stability of ternary solid dispersions of itraconazole in polyethyleneglycol 6000/hydroxypropylmethylcellulose 2910 E5 blends.

  2008cited by this paper
• Preparation of itraconazole/HP-β-CD inclusion complexes using supercritical aerosol solvent extraction system and their dissolution characteristics

  2008cited by this paper
• Physicochemical Properties of Pharmaceutical Co-Crystals: A Case Study of Ten AMG 517 Co-Crystals

  2008influential reference
• Salt formation to improve drug solubility.

  2007influential reference
• An overview of pharmaceutical cocrystals as intellectual property.

  2007cited by this paper
• A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption.

  2006cited by this paper
• Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids.

  2003cited by this paper
• Characterization of the interaction of 2-hydroxypropyl-beta-cyclodextrin with itraconazole at pH 2, 4, and 7.

  2002cited by this paper
• Formulation and evaluation of itraconazole via liquid crystal for topical delivery system.

  2001cited by this paper
• Itraconazole: pharmacology, clinical experience and future development.

  1996cited by this paper

• Enhancing the Solubility and Bioavailability of Itraconazole through Pharmaceutical Cocrystallization: A Promising Strategy for Drug Formulation.

  2025cites this paper
• Synthesis, Characterization and Dissolution Performance of Cocrystal of Cinnamic Acid with Nicotinamide: Experimental and Computation Investigation

  2025cites this paper
• KARAKTERISASI SIFAT FISIKOKIMIA DAN PENINGKATAN LAJU DISOLUSI PIPERIN-ASAM SINAMAT DENGAN TEKNIK PENGUAPAN PELARUT

  2025cites this paper
• MICRONIZED EUTECTIC MIXTURE OF FENOFIBRIC ACID-SACCHARIN FORMATION FOR SOLUBILITY AND DISSOLUTION ENHANCEMENT

  2023cites this paper
• A Review of Coformer Utilization in Multicomponent Crystal Formation

  2022cites this paper
• The first marine dual-drug cocrystal of cytarabine with 5-fluorouracil having synergistic antitumor effects shows superior biopharmaceutical peculiarities by oral administration.

  2022cites this paper
• Cocrystallization: An Approach to Improve Bioavailability by Altering Physicochemical Properties of Poorly Soluble API’s

  2021cites this paper
• PROCESSING PARACETAMOL-5-NITROISOPHTHALIC ACID COCRYSTAL USING SUPERCRITICAL CO2 AS AN ANTI-SOLVENT

  2019cites this paper